Professional Documents
Culture Documents
EDU
Immediately place all tuberculosis (TB) suspects in negative airborne infection isolation (AII) room.
Obtainsputumcontainers(36)fromthehealthdepartment(HD)orlaboratory.Collectsputumspecimenson3separatedays
oratleast8hoursapart(withonefirstmorningspecimen)Ifunabletoexpectorate,mayneedsputuminductioneitheronsite
atfacility,HDorlocalhospital).
Provideinstructionstoinmateandstaffonhowtoobtainawitnessedsputumspecimen,includingtheneedforimmediate
refrigerationaftercollectionandensuringthecontainer(bothinnerandouter)islabeledcorrectly,priortosendingspecimen
tolaboratory(ifpossible,useHDstatelab).
Obtain,collectandroutesputumspecimen(witnessed)foracidfastbacillus(AFB)smear,nucleicacidamplification(NAA)test,
MycobacteriumtuberculosisDirect(MTD)testandculture.
Obtainmedicalhistoryincludingsigns,symptomsanddurationofsymptomsofTBdisease.
Physician/ARNP/PAperformsphysicalexamination.
OfferHIVcounselingandtesting.DrawbloodforHIVtest.Obtainbaselinetests/resultsifapplicable,(i.e.,liverenzymessuch
asSerumglutamicoxaloacetictransaminase(SGOT)andSerumglutamicpyruvictransaminase(SGPT),bilirubin,creatinine,
completebloodcount(CBC),plateletcount,uricacid,asordered).
PlaceTSTatthistime,ifnotalreadydone.
Obtainweight/performbaselinevisualacuity/testingforred/greencolorblindnessifapplicable.
Obtainchestxray(CXR)ifnorecentoneisavailable.Placesurgicalmaskonpatientwhentransporting.
Day 1
NotifyHDofsuspect/casebyphoneandinwriting(usingcopyofappropriateTBmedicalreportandtreatmentplan).
HaveTBnursecasemanagerorcorrectionsnurse/designeeinstructthepatientabouttheneedformedicationsand
reactions/sideeffectsofmedications,andincludetheneedfordirectlyobservedtherapy(DOT).
ProvideeducationalinformationaboutTBandplanforfuturecare,includingtheneedformonthlyclinicvisitstoseethe
physician,nurse,orhealthdepartmentTBprogramstaff.
Obtainprescriptionforfourdrugtherapy.Medications:(Rifampin,Isoniazid,PyrazinamideandEthambutol).
AdministermedicationsusingstrictDOT(DOT=DirectlyObservedTherapy=swallowing,notsimplydeliveryofmedications)
Discussandhavepatientsignmedicalreleaseformsasnecessary.
DiscussandhavepatientsignacknowledgementofappropriateTBcounselingandeducationformsforHDandfacilitymedical
record.
Identifypatientasneedingnotificationtomedicalstaffpriortorelease.Beginplanningforeventualreleasefromfacility.
BegincontactinvestigationinconjunctionwiththeHDcasemanager(ifoneisneeded)peryourHDsinstructions.Youmaybe
instructedtowaituntilthesputumresultsreturn.DeterminethisinconjunctionwiththeHDTBProgram.
Reporttotheadministrator/directorofthefacilitythatthepatientisplacedinanegativeAirborneInfectionIsolation(AII)
roomandtheneedforassistanceifcontactinvestigationisneededorrequired.
Placewritteninformationinclassifications/releasefolderfornotificationtomedical/healthdepartmentcasemanagerpriorto
releasefromfacility.
Identifyinfectiousperiod: FROM(date) TO(date)
nd
Obtain2 earlymorningsputumspecimenorperformsputuminduction.Labelappropriatelyandsendtohealth
department/statelabforsmear,NAA(orMTD)andculture.
ObserveforstrictDOT(swallowingofmedications),includingcheckingtheamountofmedication.
Day 2
Examinethemedicationadministrationrecord(MAR)forrefusals/medicationmissing,etc.
st
Obtainsputumresultsfromday1(1 specimen)ifavailable.
ReadTSTandrecordresultsinchartinmm(ifapplicable).
IfTST+and/or+AFB/MTD,consultwithphysician/healthdepartmentcasemanager.
nd
Obtainsputumresultsfromday2(2 specimen)ifavailable.
Day 3
ReviewCXRreport/filmwithphysician/healthdepartmentcasemanager.
ContinuedailyDOTwithfourdrugtherapyfornext2monthsasdirectedbyphysicianoruntildirectedotherwisebyhealth
departmentcasemanager/physician.Monitorfornonadherence.(Note:ifHIV+,administermedicationsdailyoverfirsttwo
monthsoftreatment).
SOUTHEASTERNNATIONALTUBERCULOSISCENTER(SNTC)HTTP://SNTC.MEDICINE.UFL.EDU
INITIAL
DATE
VISIT PLEASE REMEMBER TO INITIAL AND DATE AFTER COMPLETING EACH TASK WHEN
COMPLETED
DONE
rd
Obtainsputumresultsfromday3(3 specimen)ifavailable.
Day 4
ContinuetomonitorMARtoensurepatientistakingmedicationsandnosideeffectsarenoted.
Checkreleasestatuswithclassifications/releasepersonnel.
Contactlaboratory/HDforresultsoflabtests,(NAA/MTD),baselinetests(ifnotyetreportedtoHD/correctionalfacility).
EnsureHDhassameinformation.
Day 5 Week 2
IfsmearnegativeforM.tb.,discusswithphysicianforcontinuation/changesincontactinvestigationbasedonpossibilityof
diagnosisofTB.Also,discusswithHDcasemanager/physician.
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingmedications.
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontactinvestigationwithHDcasemanager/physicianifapplicable.
Continuemedications(monitorMAR)asdirectedbyHDcasemanager/physician.
Week 3
Obtainsputumx3forsmearandcultureevery2weeks(orperlocalHDprotocol)untilnegativeforsmear/culture.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
Checkreleasestatuswithclassifications/releasepersonnel
Clinicvisitwithphysician,ARNP,PA,orRNforevaluationofstatusandmedications,includeacompletechartreviewbyhealth
personnel.
Checkweight,visualacuity,red/greencolorblindness,asapplicable.DrawandmonitorSGOTanduricacidifonPZAas
ordered.
Week 4
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Contactlaboratory/HDcasemanagerforcultureresults(maytake46weeks)ifnotyetreceived.
Schedulemonthlycasemanagementteammeetingtodiscusspatientsprogress,includeHDcasemanager.MonitorMARfor
DOT.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
Checkreleasestatuswithclassifications/releasepersonnel.
Obtainsensitivityresultsfromlaboratoryifcultureresultshavereturned.Ifsensitivetoallmedications,discusswithHD
physician/casemanagerthepossibilityofdiscontinuingEthambutolnow.
Weeks 5-7
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
Continueregularlyscheduledclinicvisitswithphysician,ARNP,PA,orRN,toincludecompletechartreviewandMARreview.
DrawSGOTanduricacidifstillonPZA/otherlabsasordered.Obtainandrecordweight.
IfstillonEthambutol,checkvisualacuityandcolorblindness.
ObtainCXR;includecomparisonwithpreviousxraytodetermineifpatientsxrayisimproving,worseningorstable.
Culturesandsensitivitystudiesshouldbebackbynow.Ifnot,checkwiththelaboratory.Ifsensitivetoallmedications,ask
physicianforordertodiscontinueEMBandPZA,whichisgenerallydiscontinuedafter2monthsoftreatment.Ifthesmears
andcultureshavenotconvertedtonegative,thepatientneedstobereevaluatedforpossibleresistancetooneormoreTB
Week 8
medications.Ifthishappens,additionalspecimensandsensitivitystudiesshouldbedone.(Note:ifthepatienthasnot
received2monthsofPZA,mayneedtotreatfor9monthsasorderedbyphysician.)
DiscusswithHDcasemanager/physicianifthissuspectisaTBcase.Isotherinformationneededtomakethisdetermination?
Noteonprogressnotesifadditionalinformationisneeded.
Discusswiththepatientifs/heisimproving/feelingbetterwithmedications.
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingmedications.
Schedulemonthlycasemanagementteammeetingtodiscusspatientsprogress,includeHDcasemanager.
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
NOTE
Ifthepatienthascavitarylesionsintheirlungs,oriftheircultureispositiveafter2monthsoftreatmentwithfourdrugsthatthepatientissensitiveto,
treatmentshouldbeextendedtoaminimumof4monthsafterthepatientconvertstheculturestonegativeperCDCguidelines.
SOUTHEASTERNNATIONALTUBERCULOSISCENTER(SNTC)HTTP://SNTC.MEDICINE.UFL.EDU
INITIAL
DATE
VISIT PLEASE REMEMBER TO INITIAL AND DATE AFTER COMPLETING EACH TASK WHEN
COMPLETED
DONE
Continuetocollectsputumx3,ifsmearsandculturesarestillpositive.Ifnegative,collectsputumsasdirectedbyHDTB
programstaff.
ContinueDOT.IfpatienthasbeenondailyDOTfor2months,begintwiceorthriceweeklyDOTafterdiscussionwithHDcase
Weeks
9-11
manager/physician.
(Note:ifHIV+,administermedicationsminimally3xweek).
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
RepeatCXRifneeded.
Monthlyclinicvisitwithphysician,ARNP,PA,orRN,includingchartreview.
DrawSGOT/labsasordered.Obtainandrecordweight.
Week 12
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Conductmonthlycasemanagementteammeetingtodiscusspatientsprogress.IncludecountyHDcasemanagerandallother
teammembers(medicationnurse,physician,etc.)(HINT:Recommendincludingcustodyorclassificationsupervisor)
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Weeks
13-15
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
Monthlyclinicvisitwithphysician,ARNP,PA,orRN,toincludecompletechartandMARreview.
DrawSGOT/labsifordered.Obtainandrecordweight.
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Week 16
Conductmonthlycasemanagementteammeetingtodiscusspatientsprogress.IncludeHDcasemanagerandallotherteam
members.(BESTPRACTICE:Recommendincludingcustodyorclassificationsupervisorintheteammeetings)
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Weeks
Continuecontactinvestigationifapplicable.
17-19
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
Monthlyclinicvisitwithphysician,ARNP,PA,orRN,toincludechartreviewandMARreview.
DrawSGOT/labsasordered.Obtainandrecordweight.
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Week 20
Conductmonthlycasemanagementteammeetingtodiscusspatientsprogress.IncludeHDcasemanagerandallotherteam
members.(BESTPRACTICE:Recommendincludingcustodyorclassificationsupervisorinteammeetings)
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Weeks
21-23
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
ContinueDOTasdirected.ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Iftreatmenthasbeencompleted,obtainfinalchestxrayandsputum,ifable.
Finalclinicvisitwithphysician/clinician(ifapplicable).Reviewchartforcompletenessorneedforcontinuation.
CompletecertificateofcompletionforTBtreatmentcard(ifapplicable).Placeinpatientsproperty.
Weeks
24-26
NotifyHDcasemanagerofcompletionoftherapy(ifapplicable).
Reviewchartforcompletionofcontactinvestigation,etc.Mayneedtocontinueafterpatientstreatmenthascompleted
(afterweek26).
Checkreleasestatuswithclassifications/releasepersonnel.
DiscusscontinuationofcontactinvestigationwithHDcasemanager/physicianifapplicable.
SOUTHEASTERNNATIONALTUBERCULOSISCENTER(SNTC)HTTP://SNTC.MEDICINE.UFL.EDU
INITIAL
DATE
VISIT PLEASE REMEMBER TO INITIAL AND DATE AFTER COMPLETING EACH TASK WHEN
COMPLETED
DONE
ContinueDOTasdirected(ifapplicable).ContinuetomonitorMARtoensurepatientistakingallmedicationsasprescribed.
Week 27 to End of Treatment
Continuecontactinvestigationifapplicable.
Monitorreleasestatuswithclassifications/releasepersonnel.
(if applicable)
Conductmonthlycasemanagementteammeetingtodiscusspatientsprogress.IncludeHDcasemanagerandallotherteam
members.
DiscussneedforcontinuationoftreatmentifneededwithHDcasemanager/physician.
Updatetreatmentplantoreflectongoingcareofpatient.
DrawSGOTandotherlabsasneeded.Obtainandrecordweightregularly.
Documentnumberofdosesinclinicalrecordonappropriatesheet.
Intheeventtheinmateistransferredorreleasedpriortocompletionoftreatment,medicationsmustbesentwiththeinmate,
alongwithacopyofthemedicaladministrationrecord(MAR),copiesofchestxrays/resultsandcopiesofanylabworkthe
Transfers or
Releases
inmatehasobtainedduringhis/herincarceration.
ThelocalHDTBnursecasemanagershouldalsobegivencopiesoftheaboveinformation,toensuretheirrecordisuptodate
andcurrent.
Contacttheagency/localHDpriortorelease/dischargeforcontinuityofcareifapplicable.
NOTE
BESTPRACTICE:Ifthepatienthascavitarylesionsintheirlungs,oriftheircultureispositiveafter2monthsoftreatmentwithfourdrugsthatthepatient
issensitiveto,treatmentshouldbeextendedtoaminimumof4monthsafterthepatientconvertstheculturestonegative.
Note:IndicateN/A(=NotApplicable)iftaskdoesnotneedtobedoneordoesnotapply.Thisindicationwillensurethatthetaskwasnotmissedor
overlookedbystaff.
COMMENTS/NOTES
CASE
NAME
AT ANY POINT, IF THE PATIENT IS RELEASED
OR TRANSFERRED TO ANOTHER FACILITY,
COMPLETE INFORMATION MUST BE SENT ID#
ALONG WITH THE INMATE PATIENT
DATEOFBIRTH